Wu, Min
Li, Xiaojiao
Yang, Deming
Wang, Meng
Zhang, Hong
Li, Cuiyun
Mai, Jiajia
Yang, Lizhi
Qi, Yunpeng
Yu, Jin-Chen
Yang, Xiaolei
Wang, Zhaohe
Gu, Cailing
Ding, Yanhua
Clinical trials referenced in this document:
Documents that mention this clinical trial
Comparison of Pharmacokinetic Similarity, Immunogenicity, and Safety of Ustekinumab and BAT2206 in Healthy Chinese Male Subjects in a Double-Blind, Randomized, Single-Dose, Parallel-Group Phase I Trial
https://doi.org/10.1007/s40259-022-00563-5
Funding for this research was provided by:
Capital Construction Funds within the provincial budget in 2020 (2020C038-1)
Article History
Accepted: 19 October 2022
First Online: 22 November 2022
Declarations
:
: This work was financially supported by the Capital Construction Funds within the provincial budget in 2020 (innovation capacity construction, Project No. 2020C038-1).
: YQ, JY, XY, ZW, and CG are employees of Bio-Thera Solutions, Ltd. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the article. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
: The Ethics Committee of Jilin University First Hospital Clinical Research Institute in Changchun City (Jilin Province, China) approved the protocols of our study.
: All participants provided written informed consent for this study.
: Not applicable.
: Data and material are available from the corresponding author upon reasonable request.
: The code is available from the corresponding author upon reasonable request.
: MW and YD performed a review of the topic, and wrote and revised the manuscript. HZ and DY took part in analyzing the pharmacokinetic data. YQ, JY, and XL drafted part of the manuscript. YQ, JY, XY, ZW, and CG helped with the analysis and interpretation of the data, and prepared all the figures and tables. YD contributed to the writing of the manuscript and provided critical revisions. All authors approved the final version of the manuscript and agreed to be accountable for all aspects of the work.
Free to read: This content has been made available to all.